---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-130805"
form_type: "8-K"
ticker: "AEON"
cik: "0001837607"
company_name: "AEON Biopharma, Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:29:08.619023+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Aeon Biopharma reduces shareholder quorum requirement to 33.34%

## Summary
- Quorum for shareholder meetings changed from a majority to 33.34% of outstanding voting power.
- Amendment to Bylaws adopted on December 18, 2024, effective immediately.
- Certificate of Amendment filed as Exhibit 3.1 with the SEC.

## SEC filing metadata
- accession: 0001104659-24-130805
- form_type: 8-K
- ticker: AEON
- cik: 0001837607
- company_name: AEON Biopharma, Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1837607/000110465924130805/0001104659-24-130805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1837607/000110465924130805/tm2431750d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-130805
- JSON: https://secwatch.observer/filing/0001104659-24-130805.json
- Plain text: https://secwatch.observer/filing/0001104659-24-130805.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.